The Olmesartan and amlodipine complex added adverse events, such as cholelithiasis

Cholelithiasis and dizziness were included in adverse events of the complex of Olmesartan and amlodipine.

On the 8^th, the Ministry of Food and Drug Safety unveiled the revision instruction (bill) of approvals for the ‘olmesartan medoxomil·amlodipine besylate’ substance after the re-deliberation result. Previously the Ministry of Food and Drug Safety prepared the revision instruction bill of ap...